Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) antibody (Biotin)
| Antigen | Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B) |
| Synonyms | DTL, BAFF, BLYS, CD257, TALL1, THANK, ZTNF4, TALL-1, TNFSF20, TNFSF13B, RGD1561519 |
| Clonality | Monoclonal (T7-241) |
| Host |
Alternatives Mouse |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Biotin |
| Application |
Alternatives Flow Cytometry (FACS)
|
| Catalog no. | ABIN179905 |
| Quantity | 100 µg |
| Price | Product not available in this region. |
| Shipping to |
|
Additional Information
| Alternative name | CD257 (BAFF| BLYS) |
| Isotype | IgG1, kappa chain |
| Clone | T7-241 |
| Description | The T7-241 antibody recognizes human BAFF also known as B cell activating factor, tumor necrosis factor ligand superfamily 13B, B lymphocyte stimulator (BLYS), TNF and APOL-related leukocyte expressed ligand 1 (TALL1), and TNF homolog that activates apoptosis, NF-kappaB, and JNK (THANK). BAFF is a type II transmembrane protein, and a member of the tumor necrosis factor ligand superfamily. BAFF can be proteolytically cleaved to form a soluble protein. BAFF, like other TNF ligand family members, forms homotrimers. The predicted molecular weight of a BAFF monomer is approximately 31 kD. BAFF is expressed on peripheral blood B and T lymphocytes, monocytes, macrophages, and dendritic cells and is upregulated by IFN-gamma and downregulated by PMA/ionomycin treatment. The T7-241 antibody has been shown to be useful for flow cytometry and ELISA. BAFF stimulates B and T cell immunity and regulates humoral immunity by binding TACI and BCMA receptors, BAFF prevents apoptosis and promotes B cell survival by binding the BAFF-specific receptor (BAFFR/BR3). The T7-241 antibody has been shown to be useful for flow cytometry and ELISA. Distribution: Peripheral blood B and T lymphocytes, monocytes, macrophages, dendritic cells. Upregulated by IFN-gamma downregulated by PMA/ionomycin treatment Function: Stimulates B and T cell immunity and regulates humoral immunity by binding TACI and BCMA receptors. Prevents apoptosis and promotes B cell survival by binding the BAFF-specific receptor (BAFFR/BR3). Synonyms: BAFF, BLYS, TNFSF13b, B cell activating factor, tumor necrosis factor ligand superfamily 13B, B lymphocyte stimulator (BLYS), TNF and APOL-related leukocyte expressed ligand 1 (TALL1), TNF homolog that activates apoptosis, NF-kappaB and JNK (THANK) Structure: Type II transmembrane protein, member of the tumor necrosis factor ligand superfamily. Can be proteolytically cleaved to form soluble protein. Forms homotrimers, predicted molecular weight of monomer approximately 31 kD. |
Application Details
| Application Notes | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining, the suggested use of this reagent is < 0.5 µg per 10 cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application. |
| Purification | The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions. The solution is free of unconjugated biotin and unconjugated antibody. |
| Buffer | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Storage | The antibody solution should be stored undiluted at 4°C. Do not freeze. |
| Restrictions | For Research Use only |
Alternatives
Alternatives for antigen "Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B)", type "Antibodies"
| Hosts | Mouse (9), Rabbit (9), Goat (4), Rat (3) |
| Reactivities | Human (24), Mouse (Murine) (5), Rat (Rattus) (3) |
| Applications | Western Blotting (WB) (22), Enzyme Immunoassay (EIA) (12), Flow Cytometry (FACS) (4), ELISA (Detection) (2), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (2), Immunofluorescence (IF) (1) |
| Conjugates | Biotin (2), FITC (1) |
| Epitopes | C-Term (3) |




Alternatives